Number Т. 16, №3 (63)

Author :   Dyagil I.S.

Analysis of CML treatment outcomes in Ukraine
Author:Dyagil I.S. Т. 16, №2 (62)
Factors associated with presence of unfavorable ТР53 and SF3B1 mutations in chronic lymphocytic leukemia patients
Authors: Abramenko I.V. Bilous N.I. Kryachok I. Martіna Z.V.... №1(21) 2016
SNP309 polymorphism in the MDM2 gene in evaluation of chronic lymphocytic leukemia outcome in combination with other prognostic markers
Authors: Bilous N.I. Abramenko I.V. Kryachok I. Martіna Z.V.... №1(17) 2015
Expression of glicoprotein Pgp-170 by the hemopoietic peripheral blood and bone marrow cells in the CML patients with different response to tyrosine kinase inhibitors therapy
Authors: Perekhrestenko T.P. Gordiyenko A.I. Tretyak N.N. Dyagil I.S.... №5 (1) 2012